Safety and Immunogenicity of a Booster Dose (50 ug) of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc) in Previously Vaccinated Healthy Adults

Trial Profile

Safety and Immunogenicity of a Booster Dose (50 ug) of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc) in Previously Vaccinated Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Ricin vaccine (Primary)
  • Indications Ricin poisoning
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top